Scintigraphic evidence of effect of infliximab on disease activity in ankylosing spondylitis.
Hadi
A
A
Hickling
P
P
Brown
M
M
Al-Nahhas
A
A
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic / Q000379:methods*; D011877:Radionuclide Imaging; D012680:Sensitivity and Specificity; D013167:Spondylitis, Ankylosing / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D013669:Technetium Tc 99m Medronate; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000069285:Infliximab; D013669:Technetium Tc 99m Medronate